CTS Spotlight at 2018 AABB Annual Meeting
Sunday, October 14, 2018 at 1:30 PM: Scientific Oral Abstract Plenary Session (BBC57) Multicenter Clinical Evaluation of a Babesia Transcription-Mediated Amplification Assay on a Fully Automated System Phillip C. Williamson, Ph.D.
Monday, October 15, 2018 at 2:30PM: (BBC2-MN3-24) Recently Acquired Hepatitis C Infections in US Blood Donors: Genotype and Geographic Distribution of NAT Yield Blood Donations across the Continental US Valerie Winkelman and Phillip C. Williamson, Ph.D.
Tuesday, October 16, 2018 at 11:45AM a: (PHP2 - TU3-23) Characteristics of HIV Infections, Including Genotypes and Drug Resistance Mutations, in Blood Donors in the US Phillip C. Williamson, Ph.D.
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...
This is the first update to the original CTS communication distributed on July 6th. As previously co...